BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10465260)

  • 1. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A.
    Bode HP; Moormann B; Dabew R; Göke B
    Endocrinology; 1999 Sep; 140(9):3919-27. PubMed ID: 10465260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
    Miura Y; Matsui H
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.
    Yada T; Itoh K; Nakata M
    Endocrinology; 1993 Oct; 133(4):1685-92. PubMed ID: 8404610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
    Hashiguchi S; Yada T; Arima T
    J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.
    Ding WG; Gromada J
    Diabetes; 1997 Apr; 46(4):615-21. PubMed ID: 9075801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release.
    Dillon JS; Lu M; Bowen S; Homan LL
    Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):182-9. PubMed ID: 15789279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the ryanodine-sensitive Ca2+ store in GLP-1-induced Ca2+ oscillations in insulin-secreting HIT cells.
    Sasaki S; Nakagaki I; Kondo H; Hori S
    Pflugers Arch; 2002 Dec; 445(3):342-51. PubMed ID: 12466936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triphenyltin impairs a protein kinase A (PKA)-dependent increase of cytosolic Na+ and Ca2+ and PKA-independent increase of cytosolic Ca2+ associated with insulin secretion in hamster pancreatic beta-cells.
    Miura Y; Matsui H
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):363-72. PubMed ID: 16837018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ca2+]i-reducing action of cAMP in rat pancreatic beta-cells: involvement of thapsigargin-sensitive stores.
    Yaekura K; Yada T
    Am J Physiol; 1998 Feb; 274(2):C513-21. PubMed ID: 9486142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells.
    Tsuboi T; da Silva Xavier G; Holz GG; Jouaville LS; Thomas AP; Rutter GA
    Biochem J; 2003 Jan; 369(Pt 2):287-99. PubMed ID: 12410638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
    Lawrence MC; Bhatt HS; Easom RA
    Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.
    Jimenez-Feltstrom J; Lundquist I; Salehi A
    Cell Tissue Res; 2005 Feb; 319(2):221-30. PubMed ID: 15558323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
    Hui H; Nourparvar A; Zhao X; Perfetti R
    Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism.
    Ding WG; Renström E; Rorsman P; Buschard K; Gromada J
    Diabetes; 1997 May; 46(5):792-800. PubMed ID: 9133546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells.
    Eliasson L; Ma X; Renström E; Barg S; Berggren PO; Galvanovskis J; Gromada J; Jing X; Lundquist I; Salehi A; Sewing S; Rorsman P
    J Gen Physiol; 2003 Mar; 121(3):181-97. PubMed ID: 12601083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 stimulates lipolysis in clonal pancreatic beta-cells (HIT).
    Yaney GC; Civelek VN; Richard AM; Dillon JS; Deeney JT; Hamilton JA; Korchak HM; Tornheim K; Corkey BE; Boyd AE
    Diabetes; 2001 Jan; 50(1):56-62. PubMed ID: 11147795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
    Nakazaki M; Crane A; Hu M; Seghers V; Ullrich S; Aguilar-Bryan L; Bryan J
    Diabetes; 2002 Dec; 51(12):3440-9. PubMed ID: 12453898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.